Skip to main content

News & Updates

news and updates icon

News & Updates

AI Coding Tools Have Revolutionized Software Development and The Law Is Scrambling to Keep Up

Authored by: Jeremy J. Gustrowsky and Charles P. Schmal Artificial intelligence has fundamentally changed the way software is written, and tools like Claude Code, Cursor, Devin, Windsurf, Lovable, and GitHub Copilot sit at the center of one of the most…

Read More

Minimizing U.S. Patent Filing Fees: A Guide for International Counsel

Authored by: Joshua P. Astin One of the most common questions we receive from foreign counsel is how to reduce U.S. patent filing costs for their clients. The U.S. patent system offers several built-in mechanisms for managing fees, but taking…

Read More

Federal Circuit Wipes Out $107.5M Verdict, Finds Cancer Treatment Patents Lack Enablement

WYETH LLC v. ASTRAZENECA PHARMACEUTICALS LP Authored by: Jeremy J. Gustrowsky The Federal Circuit has affirmed a Delaware district court’s decision to overturn a jury verdict and invalidate two Wyeth cancer treatment patents for lack of enablement, erasing a $107.5…

Read More

The Beautiful Game: Historical Inventions That Shaped Soccer as We Know It

As the FIFA World Cup captivates billions of fans, it is worth pausing to appreciate just how much invention and innovation have gone into creating the sport we know and love today. Soccer, or football as it is called in…

Read More

Federal Circuit Sends “Executable Program Code” Indefiniteness Ruling Back for a Second Look

TRACKTIME, LLC v. AMAZON.COM SERVICES LLC Authored by: Jeremy J. Gustrowsky The Federal Circuit issued a mixed decision involving two patents owned by TrackTime, LLC that were asserted against Amazon.com Services LLC and Audible, Inc. The patents (U.S. Patent Nos.…

Read More

Federal Circuit Upholds Injunction Blocking Generic Nuedexta, But Sends Bond Waiver Back to District Court

OTSUKA AMERICA PHARMACEUTICAL, INC. v. HETERO LABS LIMITED Authored by: Jeremy J. Gustrowky The Federal Circuit has affirmed a preliminary injunction preventing Hetero Labs Limited from launching a generic version of Nuedexta, a drug used to treat pseudobulbar affect and…

Read More

Indiana’s Inventive Spirit: Celebrating America’s 250th Birthday

As the United States prepares to celebrate its 250th birthday, it is a fitting time to recognize the inventors, entrepreneurs, scientists, and companies that helped shape American life. Indiana has long been known for manufacturing, agriculture, motorsports, pharmaceuticals, food production,…

Read More

Keeping Cool Through the Ages: Historical Inventions to Beat the Summer Heat

There is nothing quite like the oppressive weight of summer heat to inspire human creativity. Long before thermostats and central air conditioning became household staples, people across centuries and civilizations developed remarkably clever solutions to survive and even thrive during…

Read More

A Single Carbon Atom Costs Enanta Its Priority Date in COVID Drug Patent Battle

ENANTA PHARMACEUTICALS, INC. v. PFIZER INC. Authored by: Jeremy J. Gustrowsky In a decision highlighting the unforgiving nature of the written description requirement, the Federal Circuit affirmed a summary judgment ruling that Enanta Pharmaceuticals’ U.S. Patent 11,358,953 is invalid as…

Read More

Federal Circuit Raises the Bar on IPR Estoppel: Classification Searches Alone May Not Be Enough

IRONBURG INVENTIONS LTD. v. VALVE CORPORATION Authored by: Jeremy J. Gustrowsky In a second trip to the Federal Circuit involving a video game controller patent dispute, the court has provided important guidance on what it takes to prove that a…

Read More

U.S. Patent Maintenance Fees: Essential Deadlines and Requirements

Authored by: Joshua P. Astin For patent owners accustomed to the annuity systems used in other jurisdictions, the U.S. maintenance fee structure will feel broadly familiar in concept but differs in important ways when it comes to timing and process.…

Read More

Sotera Stipulation Violations Won’t Save Your Patent Once IPR Is Underway

HAFEMAN v. GOOGLE LLC Authored by: Jeremy J. Gustrowsky The Federal Circuit recently addressed whether a patent owner can challenge a final written decision based on a defendant’s post-institution violation of a Sotera stipulation, along with claim construction and secondary…

Read More